We serve Chemical Name:Methoxyisopropylimine CAS:37143-54-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methoxyisopropylimine
CAS.NO:37143-54-7
Synonyms:2-Propanamine, 1-methoxy-;(R,S)-1-methoxy-2-propylamine;1-methoxypropan-2-amine;MFCD00008084;1-(methoxymethyl)ethylamine;1-methoxy-2-propylamine;1-methoxy-2-propanamin;1-(methyloxy)-2-propanamine;1-Methoxy-2-propanamine;2-METHOXYISOPROPYLAMINE;Methoxyisopropylimine;±-2-Amino-1-methoxypropane;1-methoxy-2-amino-propane;1-MethoxyisopropylaMine;2-METHOXYISOPROPYLAM;2-Methoxy-1-Met;EINECS 422-550-4;(1-methyl-2-methoxy-ethyl)amine;MOIPA;METHOXYISOPROPYLAMINE
Molecular Formula:C4H11NO
Molecular Weight:89.136
HS Code:2922199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:93.7±0.0 °C at 760 mmHg
Density:0.8±0.1 g/cm3
Index of Refraction:1.407
PSA:35.25000
Exact Mass:89.084061
LogP:-0.31
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2733 3/PG 2
Packing Group:II
Contact us for information like 2-Propanamine, 1-methoxy- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,METHOXYISOPROPYLAMINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Propanamine, 1-methoxy- Use and application,METHOXYISOPROPYLAMINE technical grade,usp/ep/jp grade.
Related News: After recently opening one cell therapy plant and breaking ground on another in Massachusetts, Takeda is pivoting westward to beef up production in California. Sulpho tobias acid manufacturers As for the expansion itself, Takeda will build a new 15,000-square-foot manufacturing facility at the site and expand an existing 14,000-square-feet of production space. Takeda has been knocking around the Thousand Oaks area since 1996, the Business Times said. methyl 3-methyl-4-oxidoquinoxalin-4-ium-2-carboxylate suppliers According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. [4-[(4-cyanophenyl)methoxy]phenyl]boronic acid vendor & factory.
